Effect of age on pharmacokinetics, efficacy, and safety of galcanezumab treatment in adult patients with migraine: results from six phase 2 and phase 3 randomized clinical trials

Effect of age on pharmacokinetics, efficacy, and safety of galcanezumab treatment in adult patients with migraine: results from six phase 2 and phase 3 randomized clinical trials

Abstract Background Migraine clinical profile may change with age, making it necessary to verify that migraine treatments are equally safe and effective in older patients. These analyses evaluated the effects of patient age on the pharmacokinetics (PK), efficacy, and safety of galcanezumab for preve...

Full description

Bibliographic Details
Main Authors: Virginia L. Stauffer, Ira Turner, Phebe Kemmer, William Kielbasa, Kathleen Day, Martha Port, Tonya Quinlan, Angelo Camporeale
Format: Article
Language:English
Published: BMC 2020-06-01
Series:The Journal of Headache and Pain
Subjects:
Aging population
Elderly
Migraine
CGRP antagonist
Migraine in older adults
Migraine prevention
Online Access:http://link.springer.com/article/10.1186/s10194-020-01148-9

Internet

http://link.springer.com/article/10.1186/s10194-020-01148-9

Similar Items